Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection

被引:215
|
作者
Yang, Hwai-I
Sherman, Morris
Su, Jun
Chen, Pei-Jer
Liaw, Yun-Fan
Iloeje, Uchenna H.
Chen, Chien-Jen [1 ]
机构
[1] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan
关键词
LIVER FIBROSIS; BIOCHEMICAL MARKERS; HEART-DISEASE; PREDICTION; CIRRHOSIS; SCORE; PREVENTION; GENOTYPE; MODELS; LEVEL;
D O I
10.1200/JCO.2009.27.4456
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Counseling patients with chronic hepatitis B virus (HBV) on their individual risk of liver disease progression is challenging. This study aimed to develop nomograms for predicting hepatocellular carcinoma risk in patients with chronic hepatitis B. Patients and Methods Two thirds of the Risk Evaluation of Viral Load Elevation and Associated Liver Disease/Cancer Hepatitis B Virus (REVEAL-HBV) study cohort was allocated for model derivation (n = 2,435), and the remaining third was allocated for model validation (n = 1,218). Previously confirmed independent risk predictors included in three Cox proportional hazards regression models were sex, age, family history of hepatocellular carcinoma, alcohol consumption habit, serum ALT level, hepatitis B envelope antigen (HBeAg) serostatus, serum HBV DNA level, and HBV genotype. Regression coefficients were rounded into integer risk scores, and predicted risk over 5- and 10-year periods for each risk score was calculated and depicted in nomograms. The predictive accuracy was evaluated using the area under the receiver operating characteristic curve (AUROC) and the correlation between predicted and observed hepatocellular carcinoma risk. Results All selected risk predictors were statistically significant in all models. In each model, either HBeAg seropositivity or HBeAg seronegativity with high viral load (HBV DNA level >= 100,000 copies/mL) and genotype C infection had the highest risk scores. All AUROCs for risk prediction nomogram were >= 0.82 in both model derivation and validation sets. The correlation coefficients between the observed hepatocellular carcinoma risk and the nomogram-predicted risk were greater than 0.90 in all model derivation and validation sets. Conclusion These easy-to-use nomograms based on noninvasive clinical characteristics can accurately predict the risk of hepatocellular carcinoma in patients with chronic hepatitis B. They may facilitate risk communication between patients and clinicians.
引用
下载
收藏
页码:2437 / 2444
页数:8
相关论文
共 50 条
  • [41] Reply to: "Hepatocellular carcinoma (HCC) in the absence of cirrhosis in patients with chronic hepatitis B virus infection"
    Chayanupatkul, Maneerat
    Kanwal, Fasiha
    JOURNAL OF HEPATOLOGY, 2017, 67 (04) : 886 - 887
  • [42] Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection
    Kim, YJ
    Lee, HS
    INTERVIROLOGY, 2005, 48 (01) : 10 - 15
  • [43] Indications for liver transplantation in patients with chronic hepatitis B and C virus infection and hepatocellular carcinoma
    Fan, ST
    Cheung, ST
    Lo, CM
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2000, 15 : E181 - E186
  • [44] Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
    Xiaofei Li
    Lina Sheng
    Liwen Liu
    Yongtao Hu
    Yongxin Chen
    Lianqing Lou
    BMC Gastroenterology, 20
  • [45] Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis
    Li, Xiaofei
    Sheng, Lina
    Liu, Liwen
    Hu, Yongtao
    Chen, Yongxin
    Lou, Lianqing
    BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [46] Genetic Susceptibility to Hepatocellular Carcinoma in Patients with Chronic Hepatitis Virus Infection
    Yang, Tsai-Hsuan
    Chan, Chi
    Yang, Po-Jiun
    Huang, Yu-Han
    Lee, Mei-Hsuan
    VIRUSES-BASEL, 2023, 15 (02):
  • [47] Occult hepatitis B virus infection as a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C in whom viral eradication fails
    Miura, Yukiko
    Shibuya, Akitaka
    Adachi, Shigeru
    Takeuchi, Atsuko
    Tsuchihashi, Takeshi
    Nakazawa, Takahide
    Saigenji, Katsunori
    HEPATOLOGY RESEARCH, 2008, 38 (06) : 546 - 556
  • [48] Comparison of the risks of hepatocellular carcinoma in patients with chronic hepatitis B virus infection: estimation of direct carcinogenic effect of hepatitis B virus
    Chang, Y.
    Lee, J. -H.
    Nam, J. Y.
    Lee, H. Y.
    Cho, H.
    Cho, Y. Y.
    Cho, E. J.
    Yu, S.
    Kim, Y. J.
    Yoon, J. -H.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S482 - S482
  • [49] Liver stiffness in hepatocellular carcinoma and chronic hepatitis patients: Hepatitis B virus infection and transaminases should be considered
    Huang, Jia-Yao
    Peng, Jian-Yun
    Long, Hai-Yi
    Zhong, Xian
    Xie, Yu-Hua
    Yao, Lu
    Xie, Xiao-Yan
    Lin, Man-Xia
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (07)
  • [50] Significance of prior hepatitis B virus infection in the development of hepatocellular carcinoma in patients with chronic hepatitis C.
    Imazeki, F
    Yokosuka, O
    Hiraide, A
    Saisho, H
    HEPATOLOGY, 2002, 36 (04) : 561A - 561A